Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Net Sales

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 4.276.312.812.5423.32

What is the latest EV/Net Sales ratio of ORCHID PHARMA ?

The latest EV/Net Sales ratio of ORCHID PHARMA is 4.27 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20254.27
Mar20246.31
Mar20232.81
Mar20222.54
Mar202123.32

How is EV/Net Sales of ORCHID PHARMA Trending?

Years EV/Net Sales % Change
Mar2025 4.27
-32.33
Mar2024 6.31
124.56
Mar2023 2.81
10.63
Mar2022 2.54
-89.11
Mar2021 23.32 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Net Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹6,361.4 Cr 6.3% 1% 36.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,000.0 Cr -1.5% -1.6% 35.6% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

6.3%

1%

36.4%

SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses